Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17154348 | 0.91 | TSHR (0.51) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL18653587 | 0.89 | TSHR (0.62) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL12834917 | 0.87 | TSHR (0.53) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL10311846 | 0.84 | TSHR (0.59) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL21415446 | 0.83 | TSHR (0.64) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL21554118 | 0.81 | TSHR (0.56) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL23729602 | 0.81 | TSHR (0.77) | CNR1TSHRHPGDHTTSMN1; SMN2 | |
| SCHEMBL13347928 | 0.81 | LPAR1 (0.43) | CNR1TSHRHPGDLPAR1LPAR2 | |
| SCHEMBL27859698 | 0.81 | CNR1 (0.84) | CNR1HPGDLPAR1LPAR2ENPP2 | |
| SCHEMBL10311844 | 0.80 | TSHR (0.53) | CNR1TSHRHPGDHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426357-B2 | Multimeric conjugate | CELARES GMBH (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20100143387-A1 | MULTIMERIC CONJUGATE | WACKER CHEMIE AG (DE) | 2010-06-10 | — | — | US | disclosed |
| EP-1955712-A1 | Multimeric conjugate | Scil proteins GmbH (DE) | 2008-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143387-A1 | MULTIMERIC CONJUGATE | FCGR2A, FCGR1A, FCER2 | CNR1 3556/4885TSHR 3798/4885HPGD 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.